North America Aesthetic Filler Market 2019-2028

MARKET OUTLOOK

In its report, the publisher predicts the North American aesthetic filler Market to advance at a CAGR of 10.28% during the considered years 2019-2028. The United States and Canada form the market in this region.
In Canada, there is a large amount of young population that are persuaded towards improving their appearance for social reasons. The influence of social media, economic viability, and popularity of facial beauty, are some of the factors increasing the demand for cosmetic surgeries across the country. Among the procedures, Botox and collagen, along with non-surgical facelifts, are commonly preferred by the majority of the consumers. Additionally, according to the government, customers are now selecting injectable cosmetic procedures using aesthetic fillers to reduce facial wrinkles, further enhancing their appearance. This growth in cosmetic surgeries will augment the demand for aesthetic fillings, simultaneously boosting the aesthetic filler market’s progression in Canada.

In the United States, around 2.6 million procedures were performed using soft tissue filler in 2016, higher than the numbers in 2015, as per the American Society of Plastic Surgeons. This growth was registered due to safe and effective minimally invasive procedures. In recent times, the demand for non-aesthetic procedures, along with the growing elderly population, is enhancing the aesthetic fillers market across the country. Furthermore, the need for rejuvenating facial products to prolong the appearance of aging is anticipated to increase the demand for dermal fillers, further fueling the aesthetic filler market’s evolution across the United States.

COMPETITIVE OUTLOOK

Some of the major players in the aesthetic filler market are Sinclair Pharma, Teoxane, Galderma Pharma SA, Suneva Medical Inc, Anika Therapeutics Inc, Contura Ltd, and Laboratoires Vivacy SAS.